Josh Mandel-Brehm

Director, ProMIS Neurosciences Inc.

Companies

Camp4 Therapeutics CorpBoard member Oct 10, 2024 to now¹
Camp4 Therapeutics CorpChief executive officer Oct 10, 2024 to now¹
ProMIS Neurosciences Inc.Board member Jul 7, 2022 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Camp4 Therapeutics Corp CAMP284,968 shares³$906.2K at $3.18Aug 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 3, 2026Bought 6,551 shares at $1.65 of Camp4 Therapeutics Corp³
Sep 11, 2025Bought 6,060 shares at $1.65 of Camp4 Therapeutics Corp⁴
Oct 15, 2024Converted 605 shares of Camp4 Therapeutics Corp⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCamp4 Therapeutics Corp, Board member
2
SEC EDGARProMIS Neurosciences Inc., Board member
3
SEC EDGARCamp4 Therapeutics Corp shares after the filing of Aug 3, 2026
4
SEC EDGARForm 4 filed Sep 11, 2025
5
SEC EDGARForm 4 filed Oct 15, 2024